Friday, July 10, 2026

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip

321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
443
Patents
706
Clinical program

Softisan 378, Cannabidiol

Phase 2 · small molecule · psychological disorders: PTSD; Anxiety disorders

Softisan 378, Cannabidiol for psychological disorders: PTSD; Anxiety disorders is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

← All Disc Medicine projects Phase 2 small molecule active

Internal code 20U-0014

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Disc Medicine
Phase
Phase 2
Modality
small_molecule
Indication
psychological disorders: PTSD; Anxiety disorders
Status
active
Trials
1